Institutional Ownership Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the 367 institutions that hold shares in the stock, with a total of 184 Million shares, which have been reported (via 13F filing form) to have a value of $8.61 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Driehaus Capital Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
1,500,558
shares
|
$68.9 Million
0.57% of portfolio
|
Q1 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,498,619
shares
|
$68.8 Million
0.0% of portfolio
|
Q1 2025
Added 19.73%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
1,401,513
shares
|
$64.3 Million
0.03% of portfolio
|
Q1 2025
Reduced 8.92%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,286,847
shares
|
$59.1 Million
0.01% of portfolio
|
Q1 2025
Reduced 2.75%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
1,282,229
shares
|
$58.9 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.88%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
1,164,967
shares
|
$53.5 Million
0.0% of portfolio
|
Q1 2025
Added 17.53%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Apr 28, 2025 Q1 2025 |
1,148,292
shares
|
$52.7 Million
0.02% of portfolio
|
Q1 2025
Added 9.35%
|
|
|
Emerald Advisers, LLC
|
May 01, 2025 Q1 2025 |
1,145,491
shares
|
$52.6 Million
1.97% of portfolio
|
Q1 2025
Reduced 0.47%
|
|
|
Summit Partners Public Asset Management, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
1,129,592
shares
|
$51.8 Million
1.18% of portfolio
|
Q1 2025
New holding
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 14, 2025 Q1 2025 |
1,041,935
shares
|
$47.8 Million
0.01% of portfolio
|
Q1 2025
Added 140.59%
|
|
|
American Century Companies Inc
Kansas City, MO |
May 13, 2025 Q1 2025 |
1,027,488
shares
|
$47.2 Million
0.02% of portfolio
|
Q1 2025
Added 1.16%
|
|
|
Catalio Capital Management, LP
New York, NY |
May 15, 2025 Q1 2025 |
962,883
shares
|
$44.2 Million
8.1% of portfolio
|
Q1 2025
Added 7.17%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
946,850
shares
|
$43.5 Million
0.0% of portfolio
|
Q1 2025
Added 117.69%
|
|
|
Primecap Management CO
Pasadena, CA |
May 09, 2025 Q1 2025 |
913,200
shares
|
$41.9 Million
0.03% of portfolio
|
Q1 2025
Reduced 0.25%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
908,135
shares
|
$41.7 Million
2.51% of portfolio
|
Q1 2025
Added 212.89%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
May 13, 2025 Q1 2025 |
857,922
shares
|
$39.4 Million
0.11% of portfolio
|
Q1 2025
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
843,321
shares
|
$38.7 Million
0.07% of portfolio
|
Q1 2025
Added 253.54%
|
|
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
838,358
shares
|
$38.5 Million
0.01% of portfolio
|
Q1 2025
Added 26.08%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
800,075
shares
|
$36.7 Million
0.05% of portfolio
|
Q1 2025
New holding
|
|
|
Frontier Capital Management CO LLC
|
May 15, 2025 Q1 2025 |
769,301
shares
|
$35.3 Million
0.31% of portfolio
|
Q1 2025
Reduced 28.49%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
760,474
shares
|
$34.9 Million
0.03% of portfolio
|
Q1 2025
Added 5856.56%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
739,704
shares
|
$34 Million
0.0% of portfolio
|
Q1 2025
Reduced 39.58%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
734,227
shares
|
$33.7 Million
1.87% of portfolio
|
Q1 2025
New holding
|
|
|
Emerald Mutual Fund Advisers Trust
|
May 01, 2025 Q1 2025 |
724,354
shares
|
$33.2 Million
2.03% of portfolio
|
Q1 2025
Reduced 0.07%
|
|
|
First Turn Management, LLC
Del Mar, CA |
May 15, 2025 Q1 2025 |
656,699
shares
|
$30.1 Million
4.58% of portfolio
|
Q1 2025
Added 45.19%
|